Uterovaginal malformation

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:180062
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Uterovaginal malformation (Orphanet code 180062) is a broad category of congenital anomalies affecting the development of the uterus and vagina, which arise from the Müllerian (paramesonephric) ducts during embryonic development. These malformations encompass a wide spectrum of structural abnormalities, including uterine agenesis, unicornuate uterus, bicornuate uterus, septate uterus, didelphys uterus, vaginal agenesis, vaginal septum, and various combinations thereof. The condition primarily affects the female reproductive system and may also be associated with anomalies of the urinary tract and skeletal system, as these organ systems develop in close embryological proximity. Clinical presentation varies widely depending on the specific type and severity of the malformation. Some patients may be asymptomatic and diagnosed incidentally, while others present at puberty with primary amenorrhea, cyclic pelvic pain, or difficulty using tampons. In adulthood, uterovaginal malformations may be identified during evaluation for infertility, recurrent pregnancy loss, or obstetric complications such as preterm delivery or malpresentation. Specific well-known syndromes within this group include Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, characterized by congenital absence of the uterus and upper vagina in individuals with a normal female karyotype (46,XX) and normal secondary sexual characteristics. Diagnosis typically involves imaging studies such as pelvic ultrasound, magnetic resonance imaging (MRI), and sometimes hysteroscopy or laparoscopy. Treatment depends on the specific malformation and the patient's symptoms and reproductive goals. Surgical interventions may include hysteroscopic septum resection, vaginal dilation therapy or vaginoplasty for vaginal agenesis, and reconstructive procedures for obstructive anomalies causing pain or hematocolpos. Assisted reproductive technologies may be considered for patients with fertility challenges. A multidisciplinary approach involving gynecologists, reproductive endocrinologists, urologists, and psychologists is often recommended for comprehensive care.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

1 event
Apr 2024Retrospective Review on Uterovaginal Anomalies

Chinese University of Hong Kong

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Uterovaginal malformation.

View clinical trials →

No actively recruiting trials found for Uterovaginal malformation at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Uterovaginal malformation community →

No specialists are currently listed for Uterovaginal malformation.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Uterovaginal malformation.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Uterovaginal malformationForum →

No community posts yet. Be the first to share your experience with Uterovaginal malformation.

Start the conversation →

Latest news about Uterovaginal malformation

Disease timeline:

New recruiting trial: Retrospective Review on Uterovaginal Anomalies

A new clinical trial is recruiting patients for Uterovaginal malformation

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Uterovaginal malformation

What is Uterovaginal malformation?

Uterovaginal malformation (Orphanet code 180062) is a broad category of congenital anomalies affecting the development of the uterus and vagina, which arise from the Müllerian (paramesonephric) ducts during embryonic development. These malformations encompass a wide spectrum of structural abnormalities, including uterine agenesis, unicornuate uterus, bicornuate uterus, septate uterus, didelphys uterus, vaginal agenesis, vaginal septum, and various combinations thereof. The condition primarily affects the female reproductive system and may also be associated with anomalies of the urinary tract